Global continuous glucose monitor system Market
Medical Equipment

Continuous Glucose Monitor System Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Continuous Glucose Monitor System Market Over the Forecast Period of 2025 to 2034?

In recent times, the market size for the Continuous Glucose Monitor (CGM) system has seen a considerable expansion. The market is set to rise from $8.83 billion in 2024 to an impressive $9.67 billion in 2025, showing a compound annual growth rate (CAGR) of 15.4%. This vast growth during the historic period can be attributed to factors such as a rising elderly population, increased awareness about managing diabetes, growth in disposable income, heightened investment in research and development, and a boost in healthcare expenditure.

The market for continuous glucose monitor (CGM) systems is anticipated to witness substantial growth in the coming years, expanding to a value of $17.00 billion in 2029 with a compound annual growth rate (CAGR) of 15.1%. Factors contributing to this upswing in the forecast period include an escalating incidence of diabetes, increasing obesity rates, socio-economic changes, a rise in clinical trials, and heightened urbanization. The forecast period also indicates significant trends such as the incorporation with smart devices, enhanced usage of artificial intelligence (AI), non-invasive monitoring systems, wearable technology advancements, growth of telemedicine, and remote healthcare solutions.

What Major Innovations Are Driving the Accelerated Growth of the Continuous Glucose Monitor System Market?

The continuous glucose monitor system market is expected to flourish due to the escalating frequency of diabetes. Characterized by elevated blood sugar levels, diabetes is a persistent medical condition caused by the body’s ineffective production or utilization of insulin. Health factors like increasing obesity rates, unhealthy food habits, physical inactivity, and an elderly population largely contribute to the surge in diabetes cases. Continuous glucose monitoring (CGM) systems, with their real-time glucose measurements, enable better diabetes management by identifying patterns and flagging irregular readings. They also streamline glycemic control while reducing the dependence on frequent fingerstick testing. For example, NHS – the UK-based governmental department, in June 2024 reported a high-risk identification for developing type 2 diabetes in an additional 549,000 individuals in England in 2023. This brought the total count of people with non-diabetic hyperglycemia or pre-diabetes registered under a GP to a massive 3,615,330, marking an approximately 20% increase from the 3,065,825 in 2022. Hence, the growing frequency of diabetes is a key driving force for the expansion of the continuous glucose monitor system market.

Get Your Free Sample of the Global Continuous Glucose Monitor System Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20732&type=smp

Who Are the Top Companies Driving Innovation and Growth in the Continuous Glucose Monitor System Market?

Major companies operating in the continuous glucose monitor system market are:

• Abbott Corporation_x000D_

• Medtronic PLC_x000D_

• Murata Manufacturing Co. Ltd._x000D_

• Dexcom Inc._x000D_

• Sinocare Inc._x000D_

What Key Trends Are Currently Impacting the Continuous Glucose Monitor System Market’s Development?

Major companies in the continuous glucose monitor system market are endeavoring to develop advanced over-the-counter continuous glucose monitors (CGMs) to boost accessibility and amplify their presence amongst non-prescription users. An over-the-counter (OTC) continuous glucose monitor (CGM) is a tool that continually tracks glucose levels with no need for a prescription, thereby, offering easy and convenient independent glucose monitoring to users. To illustrate this, Abbott Laboratories, a medical device company based in the US, introduced Lingo in the United States in September 2024. Lingo, created for adults without diabetes, allows users to monitor their glucose levels, providing critical insights on the impact of diet and exercise on overall health. With a wearability period of up to 14 days, this product bolsters Abbott’s strategy to cater to the rising market populated by consumers with a focus on prediabetes management and wellbeing, devoid of requiring a prescription.

Get Instant Access to the Global Continuous Glucose Monitor System Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitor-system-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Continuous Glucose Monitor System Market?

The continuous glucose monitor system market covered in this report is segmented –

1) By Component: Transmitters, Receivers, Sensor

2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring

3) By Demography: Child Population, Adult Population

4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes

5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare

Subsegments:

1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters

2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers

3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors

Which Geographical Regions Are Pioneering Growth in the Continuous Glucose Monitor System Market?

North America was the largest region in the continuous glucose monitor (CGM) system market in 2024. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Continuous Glucose Monitor System Market?

A continuous glucose monitoring (CGM) system is a medical device designed for individuals with diabetes to continuously track their glucose levels in real time. The system usually includes a small sensor inserted under the skin that measures glucose levels in the interstitial fluid, transmitting this data to a receiver or smartphone app for easy monitoring. This technology helps users make informed decisions about insulin dosing and lifestyle choices to manage their blood sugar effectively.

Browse Through More Similar Reports By The Business Research Company:

Blood Glucose Meters Global Market Report 2025

https://thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Global Blood Glucose Test Strips Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/blood-glucose-test-strips-market

Continous Blood Glucose Monitoring Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/continous-blood-glucose-monitoring-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *